Trial Profile
Phase 2 proof-of-concept of Pamapimod in patients with MAP kinase-related indications
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 24 May 2016
Price :
$35
*
At a glance
- Drugs Pamapimod (Primary)
- Indications Rheumatoid arthritis
- Focus Proof of concept; Therapeutic Use
- 24 May 2016 New trial record